RAD51 and ovarian cancer: We and others have previously reported that resveratrol downregulates RAD51 expression and inhibits HR.[24, 32] We therefore screened the 20 stilbene molecules (ST1‐ST20) to identify a potent RAD51‐downregulating small molecule in ovarian cancer cells.